Standardization procedure for the in vitro skin permeation of anticholinergics

International Journal of Pharmaceutics

Volumn 169, Issue 1, 1998, Pages 65-73

  Bosman, Ingrid J ^a,b   Ensing, Kees ^a   De Zeeuw, Rokus A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

3H Dexetimide; Anticholinergics; In vitro permeation; Internal standard; Transdermal delivery

Indexed keywords

ALCOHOL; ATROPINE; BENZATROPINE MESILATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXETIMIDE; LAUROCAPRAM; OCTANOL; OXYPHENCYCLIMINE; PROPYLENE GLYCOL; SCOPOLAMINE BROMIDE; TROPICAMIDE;

ANIMAL TISSUE; ARTICLE; DRUG SOLUBILITY; EPIDERMIS; MOLECULAR WEIGHT; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN PERMEABILITY; SWINE;

EID: 0032581117     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00106-9     Document Type: Article

References (44)

1. Barry, B.W., 1983. Methods for studying percutaneous absorption. In: Dermatological Formulations: Percutaneous Absorption. Marcel Dekker, New York, pp. 234-295.
2. Barry, B.W., 1987. Mode of action of penetration enhancers in human skin. J. Control. Release 6, 85-97.
3. Bartek, M.J., La Budde, J.A., Maibach, H.I., 1972. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 58, 114-123.
4. Behl, C.R., Kumar, S., Malick, A.W., Patel, S.B., Char, H., Piemontese D., 1990. Choice of membranes for in vitro skin uptake studies and general experimental techniques. In: Kemppainen, B.W. Reifenrath, W.G. (Eds.), Methods for Skin Absorption. CRC Press, FL, pp. 1-21.
5. Bhatti, A.S., Scott, R.C., Dyer, A., 1988. In-vitro percutaneous absorption: pig epidermal membrane as a model for human skin. J. Pharm. Pharmacol. 40 (Suppl.), 45P.
6. Bosman, I.J., Ensing, K., de Zeeuw, R.A., 1998. Selection and evaluation of anticholinergics for transdermal drug delivery. Int. J. Pharm. 1, 75-82.
7. 3H]dexetimide by atropine. Pharm. Res. 15, 146-149.
8. Bronaugh, R.L., Collier, S.W., 1990. In vitro methods for measuring skin permeation. Cosmetics Toiletries 105, 86-93.
9. Bronaugh, R.L., Stewart, R.F., Congdon, E.R., 1982. Methods for in vitro percutaneous absorption studies II. Animal models for human skin. Toxicol. Appl. Pharmacol. 62, 481-488.
10. Chang, S.K., Riviere, J.E., 1991. Percutaneous absorption of parathion in porcine skin: Effects of dose, temperature, humidity and perfusate composition on absorptive flux. Fund. Appl. Toxicol. 17, 494-504.
11. Dick, I.P., Scott, R.C., 1992. Pig ear skin as an in-vitro model for human skin permeability. J. Pharm. Pharmacol. 44, 640-645.
12. Ensing, K., Bosman, I.J., Egberts, A.C.G., Franke, J.P., de Zeeuw, R.A., 1994. Application of radioreceptor assays for systematic toxicological analysis. 1. Procedures for radioreceptor assays for antihistaminics, anticholinergics and benzodiazepines. J. Pharm. Biomed. Anal. 12, 53-58.
13. Frantz, S.W., 1990. Instrumentation and methodology for in vitro skin diffusion cells in methodology for skin absorption. In: Kemppainen, B.W., Reifenrath, W.G. (Eds.), Methods for Skin Absorption. CRC Press, FL, pp. 35-59.
14. Friend, D.R., 1992. In vitro permeation techniques. J. Control. Release 18, 235-248.
15. Gray, G.M., Yardley, H.J., 1975. Lipid compositions of cells isolated from pig, human, and rat epidermis. J. Lipid Res. 16, 434-440.
16. Guy, R.H., Hadgraft, J., 1986. Transdermal drug delivery: the ground rules are emerging. Pharm. Int. May, 112-116.
17. Guy, R.H., Hadgraft, J., 1987. The effect of penetration enhancers on the kinetics of percutaneous absorption. J. Controlled Rel. 5, 43-51.
18. Guy, R.H., Potts, R.O., 1992. Structure-permeability relationships in percutaneous absorption. J. Pharm. Sci. 81, 603-604.
19. Hadzija, B.W., Ruddy, S.B., Scott Ballenger, E., 1992. Effect of freezing on iontophoretic transport through hairless rat skin. J. Pharm. Pharmacol. 44, 387-390.
20. Harrison, S.M., Barry, B.W., Dugard, P.H., 1984. Effects of freezing on human skin permeability. J. Pharm. Pharmacol. 36, 261-262.
21. Hawkins, G.S., Reifenrath, W.G., 1984. Development of an in vitro model for determining the fate of chemicals applied to skin. Fund. Appl. Toxicol. 4, S133-S144.
22. Hawkins, G.S., Reifenrath, W.G., 1986. Influence of skin source, pentration cell fluid, and partition coefficient on in vitro skin penetration. J. Pharm. Sci. 75, 378-381.
23. Kasting, G.B., Bowman, L.A., 1990. Electrical analysis of fresh, excised human skin: A comparison with frozen skin. Pharm. Res. 7, 1141-1146.
24. Marcarian, H., Calhoun, M.L., 1966. Microscopic anatomy of the integument of adult swine. Am. J. Vet. Res. 27, 765-772.
25. Meyer, W., Schwarz, R., Neurand, K., 1978. The skin of domestic mammals as a model for the human skin with special reference to the domestic pig. Curr. Prob. Dermatol. 7, 39-52.
26. Montagna, W., Yun, J.S., 1964. The skin of the domestic pig. J. Invest. Dermatol. 44, 11-21.
27. Monteiro-Riviere, N.A., 1986. Ultrastructural evaluation of the porcine integument. In: Tumbleson, M.E. (Ed.), Swine in Biomedical Research. Plenum Press, New York, pp. 641-655.
28. Munson, P.J., Rodbard, D., 1980. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
29. Nicolaides, N., Fu, H.C., Rice, G.R., 1968. The skin surface lipids of man compared with those of eighteen species of animals. J. Invest. Dermatol. 51, 83-89.
30. Potts, R.O., Guy, R.H., 1992. redicting skin permeability. Pharm. Res. 9, 663-669.
31. Rhoads, L.S., Baust, J.G., Van Buskirk, R.G., 1993. Structural integrity of a frozen human epidermal model can be examined with a fluorescent multiple point assay. Cryo-Letters 14, 103-114.
32. Ridout, G., Houk, J., Guy, R.H., 1992. An evaluation of structure-penetration relationships in percutaneous absorption. Farmaco 47, 869-892.
33. Riviere, J.E., Monteiro-Riviere, N.A., 1991. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. Crit. Rev. Toxicol. 21, 329-344.
34. Rosenquist, M.D., Cram, A.E., Kealey, G.P., 1988. Skin preservation at 4°C: A species comparison. Cryobiology 25, 31-37.
35. Swart, P.J., Weide, W.L., de Zeeuw, R.A., 1992. In vitro penetration of the dopamine D2 agonist N-0923 with and without Azone. Int. J. Pharm. 87, 67-72.
36. Smith, E.W., Haigh, J.M., 1992. In vitro diffusion cell design and validation II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation. Acta Pharm. Nord. 4, 171-178.
37. Southwell, D., Barry, B.W., Woodford, R., 1984. Variations in permeability of human skin within and between specimen. Int. J. Pharm. 18, 299-309.
38. Tayar, N.E., Tsai, R.S., Testa, B., Carrupt, P.A., Hansch, C., Leo, A., 1991. Percutaneous penetration of drugs: A quantitative structure-permeability relationship study. J. Pharm. Sci. 80, 744-749.
39. Tojo, K., 1987. Design and calibration of in vitro permeation apparatus. In: Chien, Y.W. (Ed.), Transdermal Controlled Systemic Medications. Marcel Dekker, New York, pp. 127-158.
40. Weber, L.W.D., 1993. The penetration of 2,3,7,8-tetrachlorodibenzo-p-dioxin into viable and non-viable porcine skin in vitro. Toxicology 84, 125-140.
41. Wiechers, J.W., 1989. The barrier function of the skin in relation to percutaneous absorption of drugs. In: Absorption, distribution, metabolism, and excretion of the cutaneous penetration enhancer Azone (Thesis), FEBO, Enschede, The Netherlands, pp. 13-42.
42. Williams, A.C., Barry, B.W., 1992. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9, 305-353.
43. Woolfson, A.D., McCafferty, D.F., McGowan, K.E., 1992. Percutaneous penentration characteristics of amethocaine through porcine and human skin. Int. J. Pharm. 78, 209-216.
44. Wotton, P.K., Møllgaard, B., Hadgraft, J., Hoelgaard, A., 1985. Vehicle effect on topical drug delivery. III. Effect of Azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 24, 19-26.